A Czech Republic supplier, with 1 awarded contract, most recently 5 months ago.
This public procurement contract involves the supply of medicinal products as specified in the attached documents. The contract is divided into five parts according to the specifications provided in the documentation. Suppliers are invited to submit their offers based on the detailed requirements ou
This public procurement contract involves the ongoing supply of immunosuppressive medications containing risankizumab, tofacitinib, apremilast, mirikizumab, deucravacitinib, voclosporin, and siltuximab over a period of 4 years, based on the current needs of the contracting authority. The total value
